Relative bioavailability of salbutamol to the lung following inhalation via a novel dry powder inhaler and a standard metered dose inhaler

British Journal of Clinical Pharmacology

Volumn 43, Issue 3, 1997, Pages 336-338

  Hindle, M ^a   Peers, E M ^b   Parry Billings, M ^b   Chrystyn, H ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b Innovata Biomed Ltd   (United Kingdom)

Author keywords

dry powder inhaler; metered dose inhaler; salbutamol

Indexed keywords

DRUG METABOLITE; SALBUTAMOL;

ADULT; ARTICLE; BIOAVAILABILITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG ELIMINATION; DRUG METABOLISM; DRUG URINE LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; INHALATIONAL DRUG ADMINISTRATION; INHALER; LUNG FUNCTION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031043719     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1997.00564.x     Document Type: Article

References (8)

1. Füller R. The Diskus: a new multidose powder device - efficacy and comparison with Turbohaler. J Aerosol Med 1995; 8, suppl 2: S11-S17.
2. Hindle M, Chrystyn H. Determination of the relative bioavailability of salbutamol to the lung following inhalation. Br J Clin Pharmacol 1992; 34: 311-315.
3. Hindle M, Newton DAG, Chrystyn H. Relative bioavailability of salbutamol to the lung following inhalation by a metered dose inhaler and a dry powder inhaler. Thorax 1993; 48: 433-434.
4. Hindle M, Chrystyn H. Relative bioavailability of salbutamol to the lung following inhalation using metered dose inhalation methods and spacer devices. Thorax 1994; 49: 549-553.
5. Hindle M, Newton DAG, Chrystyn H. Investigations of an optimal inhaler technique with the use of urinary salbutamol excretion as a measure of relative bioavailability to the lung. Thorax 1993; 48: 607-610.
6. Chege J, Chrystyn H. Salbutamol lung deposition is dependent on inhalation rate and formulation. Pharm Res 1995; 12: S-421.
7. Tomlinson HS, Corlett SA, Chrystyn H. Affect of dose in the relative lung bioavailability of salbutamol. J Aerosol Med 1995; 8: 127.
8. Rogers DF, Ganderton D. Determining equivalence of inhaled medications. Resp Med 1995; 89: 253-261.